Abstract:The Glucose transporter 1 (GLUT1) is one of the most abundant proteins within the erythrocyte membrane and is required for glucose and dehydroascorbic acid (Vitamin C precursor) transport. It is widely recognized as a key protein for red cell structure, function, and metabolism. Previous reports highlighted the importance of GLUT1 activity within these uniquely glycolysis-dependent cells, in particular for increasing antioxidant capacity needed to avoid irreversible damage from oxidative stress in humans. However, studies of glucose transporter roles in erythroid cells are complicated by species-specific differences between humans and mice. Here, using CRISPR-mediated gene editing of immortalized erythroblasts and adult CD34+ hematopoietic progenitor cells, we generate committed human erythroid cells completely deficient in expression of GLUT1. We show that absence of GLUT1 does not impede human erythroblast proliferation, differentiation, or enucleation. This work demonstrates for the first-time generation of enucleated human reticulocytes lacking GLUT1. The GLUT1-deficient reticulocytes possess no tangible alterations to membrane composition or deformability in reticulocytes. Metabolomic analyses of GLUT1-deficient reticulocytes reveal hallmarks of reduced glucose import, downregulated metabolic processes and upregulated AMPK-signalling, alongside alterations in antioxidant metabolism, resulting in increased osmotic fragility and metabolic shifts indicative of higher oxidant stress. Despite detectable metabolic changes in GLUT1 deficient reticulocytes, the absence of developmental phenotype, detectable proteomic compensation or impaired deformability comprehensively alters our understanding of the role of GLUT1 in red blood cell structure, function and metabolism. It also provides cell biological evidence supporting clinical consensus that reduced GLUT1 expression does not cause anaemia in GLUT1 deficiency syndrome.

GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunity

Plasma Cell Differentiation, Antibody Quality, and Initial Germinal Center B Cell Population Depend on Glucose Influx Rate

Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival

Distinct metabolic requirements regulate B cell activation and germinal center responses

Glucose Requirement of Antigen-Specific Autoreactive B Cells and CD4+ T Cells

The nutrient-sensing Rag-GTPase complex in B cells controls humoral immunity via TFEB/TFE3-dependent mitochondrial fitness

Regulation of humoral immune response by HIF-1α-dependent metabolic reprogramming of the germinal center reaction

Complete absence of GLUT1 does not impair human terminal erythroid differentiation

PI3K-dependant reprogramming of hexokinase isoforms controls glucose metabolism and functional responses of B lymphocytes

Fuelling B cells: dynamic regulation of B cell metabolism

Autophagy is dispensable for B-cell development but essential for humoral autoimmune responses

B Cells Promote Insulin Resistance Through Modulation of T Cells and Production of Pathogenic IgG Antibodies

Targeting BMI-1 in B cells restores effective humoral immune responses and controls chronic viral infection

Glucose-dependent glycosphingolipid biosynthesis fuels CD8 T cell function and tumor control

Aerobic glycolysis but not GLS1-dependent glutamine metabolism is critical for anti-tumor immunity and response to checkpoint inhibition

Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions

The metabolic plasticity of B cells

The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming

B cell academy of the gut: an update on gut associated germinal centre B cell dynamics

Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity